T1	Eq-Comparison 34 47	over 60 years
E1	Eq-Comparison:T1 Operator:T33 Value:T34 Temporal-Unit:T35
T2	Age 51 54	age
E2	Age:T2
T3	And 55 59	with
E3	And:T3
T4	Condition 84 103	Parkinson's disease
E4	Condition:T4 Name:T36
T5	Eq-Comparison 131 134	2-3
E5	Eq-Comparison:T5
T6	Condition 138 143	Hoehn
E6	Condition:T6
T7	Or 144 147	and
E7	Or:T7
T8	Condition 148 152	Yahr
E8	Condition:T8 Name:T37
T9	Negation 158 161	Not
E9	Negation:T9
T10	Condition 162 180	exposed to tobacco
E10	Condition:T10 Name:T38
T11	Temporal-Connection 181 187	during
E11	Temporal-Connection:T11
A1	Temporal-Connection-Type-Value E11 during
T12	Modifier 192 211	stage of their life
E12	Modifier:T12
T13	Negation 217 219	No
E13	Negation:T13
T14	Eq-Comparison 220 227	history
E14	Eq-Comparison:T14 Temporal-Period:T40
T15	Condition 231 244	lung diseases
E15	Condition:T15 Name:T41
T16	Negation 250 252	No
E16	Negation:T16
T17	Condition 253 277	laboratory abnormalities
E17	Condition:T17 Name:T42
T18	Negation 283 285	No
E18	Negation:T18
T19	Eq-Comparison 286 293	history
E19	Eq-Comparison:T19 Temporal-Period:T43
T20	Drug 318 326	nicotine
E20	Drug:T20 Name:T44
T21	Assertion 332 339	Able to
E21	Assertion:T21
A2	Assertion-Type-Value E21 hypothetical
T22	Condition 344 364	nicotine nasal spray
E22	Condition:T22
T23	Assertion 395 402	able to
E23	Assertion:T23
A3	Assertion-Type-Value E23 hypothetical
T24	Eq-Comparison 431 444	Under current
E24	Eq-Comparison:T24 Temporal-Period:T46
T25	Procedure 445 454	treatment
E25	Procedure:T25
T26	Drug 460 468	levodopa
E26	Drug:T26 Name:T47
T27	Negation 491 494	Not
E27	Negation:T27
T28	Eq-Comparison 495 514	currently receiving
E28	Eq-Comparison:T28 Temporal-Period:T49 Temporal-Period:T50
T29	Drug 517 544	monoamine oxidase inhibitor
E29	Drug:T29 Name:T51
T30	Negation 579 585	Unable
E30	Negation:T30
T31	Condition 622 643	Drug adverse reaction
E31	Condition:T31 Name:T52
T32	Condition 649 654	Death
E32	Condition:T32
T33	Eq-Operator 34 38	over
A4	Eq-Operator-Value T33 GT
T34	Eq-Value 39 41	60
T35	Eq-Temporal-Unit 42 47	years
A5	Eq-Temporal-Unit-Value T35 year
T36	Condition-Name 84 103	Parkinson's disease
T37	Condition-Name 148 152	Yahr
T38	Condition-Name 162 180	exposed to tobacco
T39	Observation-Name 192 211	stage of their life
T40	Eq-Temporal-Period 220 227	history
A6	Eq-Temporal-Period-Value T40 past
T41	Condition-Name 231 244	lung diseases
T42	Condition-Name 253 277	laboratory abnormalities
T43	Eq-Temporal-Period 286 293	history
A7	Eq-Temporal-Period-Value T43 past
T44	Drug-Name 318 326	nicotine
T45	Drug-Name 344 364	nicotine nasal spray
T46	Eq-Temporal-Period 437 444	current
A8	Eq-Temporal-Period-Value T46 present
T47	Drug-Name 460 468	levodopa
T48	Stability 474 480	stable
A9	Stability-Value T48 stable
T49	Eq-Temporal-Period 495 504	currently
A10	Eq-Temporal-Period-Value T49 present
T50	Eq-Temporal-Period 505 514	receiving
A11	Eq-Temporal-Period-Value T50 present
T51	Drug-Name 517 544	monoamine oxidase inhibitor
T52	Condition-Name 622 643	Drug adverse reaction